VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 89 filers reported holding VERONA PHARMA PLC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $895,327 | -32.6% | 54,928 | -12.6% | 0.00% | -50.0% |
| Q2 2023 | $1,328,120 | -5.4% | 62,825 | -10.1% | 0.00% | 0.0% |
| Q1 2023 | $1,403,612 | +8.0% | 69,901 | +40.5% | 0.00% | 0.0% |
| Q4 2022 | $1,300,020 | +176.0% | 49,752 | +7.9% | 0.00% | +100.0% |
| Q3 2022 | $471,000 | +2843.8% | 46,095 | +1100.4% | 0.00% | – |
| Q2 2022 | $16,000 | -15.8% | 3,840 | 0.0% | 0.00% | – |
| Q1 2022 | $19,000 | -26.9% | 3,840 | 0.0% | 0.00% | – |
| Q4 2021 | $26,000 | +23.8% | 3,840 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -16.0% | 3,840 | 0.0% | 0.00% | – |
| Q2 2021 | $25,000 | -21.9% | 3,840 | 0.0% | 0.00% | – |
| Q1 2021 | $32,000 | +18.5% | 3,840 | 0.0% | 0.00% | – |
| Q4 2020 | $27,000 | +12.5% | 3,840 | 0.0% | 0.00% | – |
| Q3 2020 | $24,000 | +33.3% | 3,840 | 0.0% | 0.00% | – |
| Q2 2020 | $18,000 | +12.5% | 3,840 | 0.0% | 0.00% | – |
| Q1 2020 | $16,000 | -27.3% | 3,840 | 0.0% | 0.00% | – |
| Q4 2019 | $22,000 | +22.2% | 3,840 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | -10.0% | 3,840 | 0.0% | 0.00% | – |
| Q2 2019 | $20,000 | -20.0% | 3,840 | 0.0% | 0.00% | – |
| Q1 2019 | $25,000 | -28.6% | 3,840 | 0.0% | 0.00% | – |
| Q4 2018 | $35,000 | -27.1% | 3,840 | 0.0% | 0.00% | – |
| Q3 2018 | $48,000 | -7.7% | 3,840 | 0.0% | 0.00% | – |
| Q2 2018 | $52,000 | -32.5% | 3,840 | 0.0% | 0.00% | – |
| Q1 2018 | $77,000 | – | 3,840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |